FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37358879> ?p ?o ?g. }

• Q37358879 description "article científic" @default.
• Q37358879 description "article scientifique" @default.
• Q37358879 description "articolo scientifico" @default.
• Q37358879 description "artigo científico" @default.
• Q37358879 description "artículu científicu espublizáu en 2008" @default.
• Q37358879 description "bilimsel makale" @default.
• Q37358879 description "scientific article published on 14 April 2008" @default.
• Q37358879 description "vedecký článok" @default.
• Q37358879 description "vetenskaplig artikel" @default.
• Q37358879 description "videnskabelig artikel" @default.
• Q37358879 description "vědecký článek" @default.
• Q37358879 description "wetenschappelijk artikel" @default.
• Q37358879 description "wissenschaftlicher Artikel" @default.
• Q37358879 description "наукова стаття, опублікована у квітні 2008" @default.
• Q37358879 description "научни чланак" @default.
• Q37358879 description "مقالة علمية نشرت في 14 أبريل 2008" @default.
• Q37358879 name "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 name "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 name "Anti-IL-5" @default.
• Q37358879 type Item @default.
• Q37358879 label "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 label "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 label "Anti-IL-5" @default.
• Q37358879 prefLabel "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 prefLabel "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 prefLabel "Anti-IL-5" @default.
• Q37358879 P1433 Q37358879-3D85F442-85E5-45AA-9F0F-C903F2F2728C @default.
• Q37358879 P1476 Q37358879-365F9E5D-9B11-47F2-BB9E-04001248C091 @default.
• Q37358879 P2093 Q37358879-19E51686-201C-4F8D-9B58-D2BC28CC186F @default.
• Q37358879 P2093 Q37358879-239FF542-7B06-4281-BC97-DA5CE71CC7DD @default.
• Q37358879 P2093 Q37358879-4D1E5EC3-688A-4B72-A49B-92869A7223A0 @default.
• Q37358879 P2093 Q37358879-656FEA20-B628-45F6-9FAB-86FB03F06EC1 @default.
• Q37358879 P2093 Q37358879-86DE19A8-4ACF-4089-B7C2-953789941F03 @default.
• Q37358879 P2093 Q37358879-C9ECCD3D-7247-49B9-91A7-6CE62F424255 @default.
• Q37358879 P2093 Q37358879-F8C03238-88E8-4F79-AEA4-20C1C034ED87 @default.
• Q37358879 P2860 Q37358879-015BFEC0-FD5F-4ECE-8DAA-CB5C9D10F38F @default.
• Q37358879 P2860 Q37358879-0737EB51-9446-45A7-8350-1EDEF0F1188A @default.
• Q37358879 P2860 Q37358879-0B80BC3C-D249-4B03-B715-12567BF907AA @default.
• Q37358879 P2860 Q37358879-14141859-B7B5-4963-98A1-6C30F1E8E27B @default.
• Q37358879 P2860 Q37358879-16F986D9-1060-4DEF-A46B-BF5C0096E9E9 @default.
• Q37358879 P2860 Q37358879-22387A72-DEE1-44EB-8648-B3832E7C721E @default.
• Q37358879 P2860 Q37358879-3AA2858C-9CA3-4C0C-8926-6D2BB9F4985C @default.
• Q37358879 P2860 Q37358879-3AC200E7-C75B-406E-8636-7DBB988272E9 @default.
• Q37358879 P2860 Q37358879-4161CF7D-238A-42A0-B7AD-453CC55965BD @default.
• Q37358879 P2860 Q37358879-418D6DEC-49E2-4296-B84E-2062A1BBE642 @default.
• Q37358879 P2860 Q37358879-49448731-D83A-4EB7-A781-794DB07875E2 @default.
• Q37358879 P2860 Q37358879-4F11B3E0-0D1E-4E6E-9563-5628DC5D3BA4 @default.
• Q37358879 P2860 Q37358879-5B556493-CF4F-45F3-9E5E-846AF822C7AF @default.
• Q37358879 P2860 Q37358879-662F58F8-744A-4D96-ACC9-ECECFD97E55C @default.
• Q37358879 P2860 Q37358879-675A508B-E286-4D91-8AC1-1D0CAD807F76 @default.
• Q37358879 P2860 Q37358879-70F0D66C-18F2-4C92-801B-5FBCD259CFF0 @default.
• Q37358879 P2860 Q37358879-811B2B31-771C-454C-8A70-C9A3C8F337A3 @default.
• Q37358879 P2860 Q37358879-81C64E42-3B2C-4032-BB9A-9797E28C7157 @default.
• Q37358879 P2860 Q37358879-83A52F46-9D04-4423-A170-88380DB26E3C @default.
• Q37358879 P2860 Q37358879-9B3CBFDC-2792-4AD7-BEA7-FCE61AA83F29 @default.
• Q37358879 P2860 Q37358879-9C9F40AC-8230-4B57-9C48-1AB43ADD1E18 @default.
• Q37358879 P2860 Q37358879-A7F38B8F-FB1B-4A46-B082-E0329435FF85 @default.
• Q37358879 P2860 Q37358879-B006A360-6AD4-46FD-88B6-2924A540AEA8 @default.
• Q37358879 P2860 Q37358879-B460E378-16CD-4D99-AE25-4792C546689E @default.
• Q37358879 P2860 Q37358879-B4CBAD9E-E535-44F6-836E-0EF2A08278CF @default.
• Q37358879 P2860 Q37358879-B68A5221-5B58-4974-8EB4-0821D143AA62 @default.
• Q37358879 P2860 Q37358879-B7F853AE-5433-4FC3-A0B2-3B0D899B2A67 @default.
• Q37358879 P2860 Q37358879-D3B5FC4E-04BE-410D-9C87-EF6C63D2FB89 @default.
• Q37358879 P2860 Q37358879-D6BD3C34-303C-4C30-BABB-55A723591526 @default.
• Q37358879 P2860 Q37358879-E4A25617-4A10-4541-9404-2C5C37C930F0 @default.
• Q37358879 P2860 Q37358879-ED139BC1-09E1-432F-95A8-7CFC0A912560 @default.
• Q37358879 P2860 Q37358879-EE530D93-2CA8-4811-A34F-0AF19A09341E @default.
• Q37358879 P2860 Q37358879-EF0D12F9-7059-4247-9789-0887FD58B88D @default.
• Q37358879 P2860 Q37358879-F51A4BA9-F407-4B25-A6BF-0B436F7A0009 @default.
• Q37358879 P2860 Q37358879-FFB0092F-3F5C-4BC4-AADF-ADC62486B096 @default.
• Q37358879 P304 Q37358879-3BCBC01B-8199-4559-BF98-32A5EA8A32FC @default.
• Q37358879 P31 Q37358879-1FA8A66D-1792-41B8-9277-797A4CF15E6D @default.
• Q37358879 P356 Q37358879-C3FC40DC-81DF-4C58-9391-3A9BD3760CDC @default.
• Q37358879 P407 Q37358879-1FC9C2CB-5A62-4EC6-97E0-0B5C0BC1D6BE @default.
• Q37358879 P433 Q37358879-01DA187E-72E1-4931-9BFF-B92774F9AC4D @default.
• Q37358879 P478 Q37358879-A51A5765-4DC7-4F6A-815C-C6BA25A02CBD @default.
• Q37358879 P577 Q37358879-8A21DAE8-B10F-46D6-9CF8-9264DC44A507 @default.
• Q37358879 P5875 Q37358879-BBAB6649-2552-416C-A086-DE8DF52411EE @default.
• Q37358879 P698 Q37358879-CA9F1856-7F99-445F-B3D7-C19366ED9947 @default.
• Q37358879 P921 Q37358879-FB8BFBB8-285E-4F2C-B257-69DB8DA297D6 @default.
• Q37358879 P932 Q37358879-D7D09A78-7DF4-433A-A7BF-AC31E9DFA9B3 @default.
• Q37358879 P356 J.JACI.2008.02.033 @default.
• Q37358879 P698 18410960 @default.
• Q37358879 P1433 Q7743550 @default.
• Q37358879 P1476 "Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels" @default.
• Q37358879 P2093 "Alexandra H Filipovich" @default.
• Q37358879 P2093 "Amal H Assa'ad" @default.
• Q37358879 P2093 "Bridget K Buckmeier" @default.
• Q37358879 P2093 "Joyce M Villanueva" @default.
• Q37358879 P2093 "Marc E Rothenberg" @default.
• Q37358879 P2093 "Miguel L Stein" @default.
• Q37358879 P2093 "Yoshiyuki Yamada" @default.
• Q37358879 P2860 Q22009006 @default.
• Q37358879 P2860 Q24682860 @default.
• Q37358879 P2860 Q27824793 @default.
• Q37358879 P2860 Q28145386 @default.
• Q37358879 P2860 Q28257501 @default.
• Q37358879 P2860 Q34503956 @default.
• Q37358879 P2860 Q34534119 @default.
• Q37358879 P2860 Q34762186 @default.

• next